C12N 2770/20052
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2770/20052 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 7 US grants and 38 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 38
- Assignees
- 38
- Inventors
- 136
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 3 |
| 2022 | 0 | 3 |
| 2023 | 0 | 8 |
| 2024 | 2 | 11 |
| 2025 | 0 | 7 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified S2 subunit of the coronavirus spike protein14 Apr 2026US 12,600,751 B2
- CRISPR-based programmable RNA editing12 Nov 2024US 12,139,731 B2National Institutes of Health (Nih), U.S. Dept. of Health and Human Services (Dhhs), U.S. Government
- Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine9 Apr 2024US 11,952,400 B2Tecon Biopharmaceutical Co., Ltd.
- Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)15 May 2018US 9,969,777 B2The Pirbright Institute
- Cell line for producing coronaviruses15 Feb 2011US 7,888,102 B2Crucell Holland B. V.
- Method for preparing corona virus-like particles and vaccine comprising the same16 Jul 2026US 2026/0201414 A1National Defense Medical University
- Noble cold-adapted attenuated mers-cov23 Apr 2026US 2026/0108596 A1Pioneervaccine Inc.
- Sars-cov-2 lacking the envelope protein as an attenuated vaccine virus against covid-1925 Dec 2025US 2025/0387467 A1Wisconsin Alumni Research Foundation
- Biologically produced nucleic acid for vaccine production12 Jun 2025US 2025/0188127 A1UniversitäT Basel
- Plasmid dna purification methods1 May 2025US 2025/0137024 A1Glaxosmithkline Biologicals SA
Most cited
By later US patents